Ownership history in FEDERATED HERMES, INC. · 20 quarters on record
This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in ABCELLERA BIOLOGICS INC (ABCL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,141 | -49,859 | -94.1% | 0.00% | $16K | $5.03 |
| 2025 Q2 | REDUCED | 53,000 | -894,751 | -94.4% | 0.00% | $182K | $3.43 |
| 2025 Q1 | ADDED | 947,751 | +31,514 | +3.4% | 0.00% | $2.1M | $2.23 |
| 2024 Q4 | REDUCED | 916,237 | -1,366,459 | -59.9% | 0.01% | $2.7M | $2.93 |
| 2024 Q3 | REDUCED | 2,282,696 | -443,320 | -16.3% | 0.01% | $5.9M | $2.60 |
| 2024 Q2 | REDUCED | 2,726,016 | -89,443 | -3.2% | 0.02% | $8.1M | $2.96 |
| 2024 Q1 | REDUCED | 2,815,459 | -302,221 | -9.7% | 0.03% | $12.8M | $4.53 |
| 2023 Q4 | REDUCED | 3,117,680 | -136,673 | -4.2% | 0.04% | $17.8M | $5.71 |
| 2023 Q3 | REDUCED | 3,254,353 | -119,702 | -3.5% | 0.04% | $15.0M | $4.60 |
| 2023 Q2 | ADDED | 3,374,055 | +469,796 | +16.2% | 0.05% | $21.8M | $6.46 |
As of 2025 Q4 — sorted by position size